Clinical Trial Update: Niapsan as Add -on Therapy to Antipsychotic Treatment in First Episode Psychosis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Niapsan as add-on therapy to antipsychotics in first-episode psychosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychosis

Drugs mentioned

• Niapsan

Snippet

Sponsor: Nova Scotia Health Authority | Conditions: Psychosis | Phase 3 | Status: COMPLETED